Editas Medicine (NQ: EDIT )
5.540
+0.070
(+1.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 12, 2024
Add to My Watchlist
Headline News about Editas Medicine
![](https://g.foolcdn.com/editorial/images/711855/invitae.jpg)
![](https://g.foolcdn.com/editorial/images/709891/physician-shaking-patients-hand.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/edit_logo_light__796db60d07928674d783a74bde03fba4.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7880.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/709916/dna-sequencing-genome-science-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9296.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2462.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image-palo_alto_networks.jpg?width=1200&height=800&fit=crop)
Palo Alto To Surge Around 38%? Plus This Analyst Predicts $65 For Helmerich & Payne
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image-intuit.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image-gap_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image37.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7742.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/17/aapharma_11.png?width=1200&height=800&fit=crop)
BMO Initiates Coverage On This Gene Editing Spearhead
June 17, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/edit_logo_light__796db60d07928674d783a74bde03fba4.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21677.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Intraday Session
November 17, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image13.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21632.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 17, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6916.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4600.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
September 29, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2019/01/stock-gene-03-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/03/biotech10.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_a_1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/07/biotech10_0.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/07/premkt_movers.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.